On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

1387

HTML

2244

Figures (1-1)

185

Tables (1-2)

164

Sum=3980

Sep 21, 2005 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Sep 21, 2005; 11(35): 5540-5544
Published online Sep 21, 2005. doi: 10.3748/wjg.v11.i35.5540

Full Size Figure Download Figure

Figure 1 Metabolization process of thiopurines.

Citation: Boer NK, Derijks LJ, Gilissen LP, Hommes DW, Engels LG, Boer SY, Hartog GD, Hooymans PM, Mäkelburg AB, Westerveld BD, Naber AH, Mulder CJ, Jong DJ. On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients. World J Gastroenterol 2005; 11(35): 5540-5544
URL: https://www.wjgnet.com/1007-9327/full/v11/i35/5540.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i35.5540